Literature DB >> 14680348

Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.

Philip I Haigh1, L Andrew DiFronzo, David R McCready.   

Abstract

OBJECTIVE: To determine in patients with localized primary melanoma of the trunk or extremities the optimal excision margin that achieves the highest disease-free survival and overall survival and the lowest local recurrence rate. DATA SOURCES: Trials comparing 2 different excision margins were identified by searching MEDLINE from 1966 to May 2002 using the term "melanoma," subheading "surgery," and limiting the search to human studies and randomized controlled trials (RCTs). Additional studies were found using the MeSH term "surgical procedures, operative," combining with "melanoma," and limiting to human studies. We searched EMBASE and the Cochrane Library in May 2002 using similar terminology. No language restriction was applied. STUDY SELECTION: We selected studies for the overview using the following inclusion criteria: design--an RCT with wide excision versus narrower excision (margin width was not specified a priori); population--adult patients (> 18 yr) with cutaneous melanoma of the trunk or extremities without evidence of metastasis; intervention--surgical excision of the primary melanoma; and outcomes--at least 1 of overall survival, disease-free survival, local recurrence, wound complications and necessity for skin grafting. DATA EXTRACTION: Information was abstracted for each outcome reported in the studies, and results were pooled by consensus. Statistical analysis was performed using RevMan 4.1 (The Cochrane Collaboration) software program. Relative risk and risk difference were reported with 95% confidence intervals. The number needed to harm was calculated for the need for skin grafting by taking the inverse of the risk difference. DATA SYNTHESIS: Three trials and their follow-up studies met the inclusion criteria and included 2087 adults with localized cutaneous melanoma of the trunk or extremities. No statistically significant differences were found between wide surgical excision (margins ranging from 3-5 cm) and narrower surgical excision (margins ranging from 1-2 cm) with respect to mortality, disease-free survival or local recurrence rate.
CONCLUSIONS: Surgical excision margins no more than 2 cm around a melanoma of the trunk or extremities are adequate; overall survival, disease-free survival and recurrence rate are not adversely affected compared with a wider excision. There is more data to support a 2-cm margin than a 1-cm margin as the minimum margin of excision. Surgical margins should be no less than 1 cm around the primary melanoma.

Entities:  

Mesh:

Year:  2003        PMID: 14680348      PMCID: PMC3211773     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  20 in total

1.  Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I.

Authors:  N C PETERSEN; D C BODENHAM; O C LLOYD
Journal:  Br J Plast Surg       Date:  1962-01

2.  Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

Authors:  C P Karakousis; C M Balch; M M Urist; M M Ross; T J Smith; A A Bartolucci
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

3.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

4.  Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.

Authors:  C M Balch; S J Soong; T Smith; M I Ross; M M Urist; C P Karakousis; W J Temple; M C Mihm; R L Barnhill; W R Jewell; H J Wanebo; R Desmond
Journal:  Ann Surg Oncol       Date:  2001-03       Impact factor: 5.344

5.  Analysis of local recurrence and optimizing excision margins for cutaneous melanoma.

Authors:  A K Ng; W O Jones; J H Shaw
Journal:  Br J Surg       Date:  2001-01       Impact factor: 6.939

Review 6.  Surgical treatment of malignant melanoma.

Authors:  C P Karakousis
Journal:  Surg Clin North Am       Date:  1996-12       Impact factor: 2.741

7.  Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.

Authors:  G Cohn-Cedermark; L E Rutqvist; R Andersson; M Breivald; C Ingvar; H Johansson; P E Jönsson; L Krysander; C Lindholm; U Ringborg
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

8.  Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.

Authors:  U Ringborg; R Andersson; J Eldh; B Glaumann; L Hafström; S Jacobsson; P E Jönsson; H Johansson; L Krysander; B Lagerlöf
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

9.  [Surgical treatment of superficial melanoma of the skin].

Authors:  L V Demidov; A S Barchuk
Journal:  Vopr Onkol       Date:  1998

10.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Authors:  C M Balch; M M Urist; C P Karakousis; T J Smith; W J Temple; K Drzewiecki; W R Jewell; A A Bartolucci; M C Mihm; R Barnhill
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

View more
  15 in total

Review 1.  Surgery and sentinel lymph node biopsy.

Authors:  Mark B Faries; Donald L Morton
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

2.  Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Authors:  Travis E Grotz; Svetomir N Markovic; Lori A Erickson; William S Harmsen; Marianne Huebner; David R Farley; Barbara A Pockaj; John H Donohue; Franklin H Sim; Clive S Grant; Sanjay P Bagaria; Thomas C Shives; Charles M Balch; James W Jakub
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

Review 3.  State of melanoma: an historic overview of a field in transition.

Authors:  Vikram C Gorantla; John M Kirkwood
Journal:  Hematol Oncol Clin North Am       Date:  2014-06       Impact factor: 3.722

Review 4.  Primary Melanoma: from History to Actual Debates.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

5.  XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.

Authors:  Gabriela Vilas Bôas Gomez; Cristiane de Oliveira; José Augusto Rinck-Junior; Aparecida Machado de Moraes; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2015-10-02

Review 6.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

7.  Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study.

Authors:  Linda C Harlan; Charles F Lynch; Rachel Ballard-Barbash; Christopher Zeruto
Journal:  Melanoma Res       Date:  2011-12       Impact factor: 3.599

Review 8.  Malignant melanoma (non-metastatic).

Authors:  Philip Savage
Journal:  BMJ Clin Evid       Date:  2007-06-01

9.  Thick melanoma: prognostic value of positive sentinel nodes.

Authors:  Lenka Vermeeren; Fred W C van der Ent; Prapto S H Sastrowijoto; Karel W E Hulsewé
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 10.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.